News about Global Pharma

AstraZeneca and Ionis' Wainua Granted First-Ever Regulatory Approval in US

AstraZeneca and Ionis’ Wainua (eplontersen) has been approved in the US for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults, commonly referred to as hATTR-PN or ATTRv-PN. Wainua is the only approved medicine for the treatment of ATTRv-PN that can be self-administered via an auto-injector.

Global Pharma | 26/12/2023 | By Manvi |  578

Thermo Fisher Scientific Announces Launch of Innovative CorEvitas Pharmacovigilance Platform

Thermo Fisher Scientific Inc. announced the launch of CorEvidence, a proprietary cloud-based data lake platform optimizing pharmacovigilance case processing and safety data management processes.

Global Pharma | 22/12/2023 | By Manvi |  749

Natco Pharma Ltd and Breckenridge Dismissed from Antitrust Lawsuit

The plaintiffs voluntarily dismissed Breckenridge Pharmaceutical Inc. and Natco Pharma Limited from the case.

Global Pharma | 22/12/2023 | By Manvi |  477

Venus Remedies Achieves Marketing Authorizations for Docetaxel in Israel and Cytarabine in Colombia

Venus Remedies announce dual achievements in securing marketing authorisations for three variants of Docetaxel in Israel and Cytarabjne 100MG in Colombia.

Global Pharma | 22/12/2023 | By Manvi |  631

Bain Capital-Backed Emcure Pharma Files Fresh IPO Papers with Sebi

Bain Capital-backed Emcure Pharmaceuticals has filed fresh preliminary papers with capital markets regulator Sebi to raise funds through an Initial Public Offering (IPO).

Global Pharma | 21/12/2023 | By Manvi |  1124

Tower Cold Chain Partnership Unveiled in China

Tower Cold Chain has reinforced its global availability by partnering with a Shanghai-based organisation, Tower & Winner Solutions (TWS), to drive the growth of Tower’s temperature-controlled passive containers across the Chinese market.

Global Pharma | 21/12/2023 | By Manvi |  486

Nirma Gets CCI Nod for Picking up Majority Stake in Glenmark Life Sciences

The Competition Commission of India (CCI) said it cleared Nirma’s acquisition of majority shareholding of Glenmark Life Sciences Ltd.

Global Pharma | 21/12/2023 | By Manvi |  614

Aurobindo Subsidiary in Tirupati Classified as VAI by US FDA

The inspection was conducted at Unit IV of APL Healthcare Limited, a wholly-owned subsidiary of the company, situated at Menakuru Village, under the Naidupeta Mandal, in Tirupati District of Andhra Pradesh.This is a formulation manufacturing facility.

Global Pharma | 21/12/2023 | By Manvi |  1978

Piramal Pharma Expands ADC Manufacturing Facility in Scotland

Piramal Pharma Solutions, a CDMO, part of Piramal Pharma Ltd., opened its expanded antibody-drug conjugate (ADC) manufacturing facility in Grangemouth, Scotland.

Global Pharma | 20/12/2023 | By Manvi |  972

Shweta Rai to Take Over as Managing Director of Bayer Zydus Pharma Private Limited

Bayer announced that Shweta Rai will take over as Managing Director of Bayer Zydus Pharma Private Limited and Country Division Head (CDH) for Bayer’s Pharmaceuticals Business in South Asia effective, January 1, 2024.

Global Pharma | 20/12/2023 | By Manvi |  800